Skip to main content
Home
language-selector-globe Ireland | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | es
Brazil | pt
Canada | fr
Canada | en
Central America | es
Colombia | es
Mexico | es
United States | en
Venezuela | vs
Australia | en
Bangladesh | en
Hong Kong S.A.R. | zh
India | en
Indonesia | en
Japan | ja
Korea | ko
Mainland China | zh
Malaysia | en
Pakistan | en
Philippines | en
Singapore | en
Taiwan | zh
Austria | de
Belgium | nl
Belgium | fr
Bulgaria | bg
Czech Republic | en
Czech Republic | cs
Denmark | da
Estonia | et
Finland | fi
France | fr
Germany | de
Greece | el
Hungary | hu
Ireland | en
Italy | it
Latvia | lv
Lithuania | lt
Netherlands | nl
Norway | no
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Serbia | sr
Slovakia | sk
Spain | es
Sweden | sv
Switzerland | fr
Switzerland | de
United Kingdom | en
Global | en
Novartis Foundation | en
Sandoz | en
Egypt | en
Israel | he
South Africa | en
Turkey | tr
language-selector-globe Ireland
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | es
Australia | en
Austria | de
Bangladesh | en
Belgium | nl
Belgium | fr
Brazil | pt
Bulgaria | bg
Canada | fr
Canada | en
Central America | es
Colombia | es
Czech Republic | en
Czech Republic | cs
Denmark | da
Egypt | en
Estonia | et
Finland | fi
France | fr
Germany | de
Global | en
Greece | el
Hong Kong S.A.R. | zh
Hungary | hu
India | en
Indonesia | en
Ireland | en
Israel | he
Italy | it
Japan | ja
Korea | ko
Latvia | lv
Lithuania | lt
Mainland China | zh
Malaysia | en
Mexico | es
Netherlands | nl
Norway | no
Novartis Foundation | en
Pakistan | en
Philippines | en
Poland | pl
Portugal | pt
Romania | ro
Russia | ru
Sandoz | en
Serbia | sr
Singapore | en
Slovakia | sk
South Africa | en
Spain | es
Sweden | sv
Switzerland | fr
Switzerland | de
Taiwan | zh
Turkey | tr
United Kingdom | en
United States | en
Venezuela | vs
    • About 
      • Novartis in Ireland 
      • Strategy 
      • Country Leadership Team 
      • Contact 
      Novartis office About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Education and Awareness 
      • Patient Resources 
      • Adverse Event Reporting 
      • Novartis Societal Impact 
      Novartis works with the patient community around the world to discover new ways to improve Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs. Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Environmental Sustainability 
      As a global company, Novartis has a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective. ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      news landingpage_0 News
    • Careers 
      • Career Search 
      • Working in Novartis Ireland 
      • Learning and Development 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity & Inclusion 
      • Awards and Recognition 
      Careers 769 million lives touched by our products Careers
    • Coronavirus 
      covid 10 grey image_0_0 Coronavirus
    Scientist working at Novartis Home

Stories

Story Navigation
  • All Topics
  • Education & Awareness
  • Corporate
  • People and Culture
icon
  • Picture of Audrey_0
    Corporate
    Mar 17, 2022
    An Interview with our Novartis Ireland Country President
    Corporate
  • Cell and Gene Image_0
    Corporate
    Mar 17, 2022
    Making Possible: Stepping toward a future with cell and gene therapy
    Corporate
  • Novartis manufacturing site in Switzerland_0
    Corporate
    Mar 17, 2022
    Novartis utilizing manufacturing capacity to help in the fight against COVID-19
    Corporate
  • Other Elm Park pic_0
    Corporate
    Mar 17, 2022
    Reimagining Science in #InnovateForLife Campaign
    Corporate
  • Novartis MS Innovation Prize_0_0
    Corporate
    Mar 17, 2022
    Novartis Announces Winners of the Innovation Prize for Assistive Tech
    Corporate
  • holdfirm campaign logo jpeg small_0_0
    Corporate
    Mar 17, 2022
    Novartis Ireland is supporting #HoldFirm
    Corporate
  • covid essay hero image_0
    Corporate
    Mar 17, 2022
    A visual tour of scientific strategies for combating coronavirus
    Corporate
  • covid 10 grey image_0
    Corporate
    Mar 17, 2022
    Novartis Ireland providing a broad range of initiatives to respond to communities impacted by COVID-19
    Corporate
  • Trinity College Picture_0
    Corporate
    Mar 17, 2022
    Novartis Partnership with Trinity Centre for People with Intellectual Disabilities
    Corporate
  • Story 2 Group photo of Novartis Executives_0
    Corporate
    Mar 17, 2022
    Novartis opens facility for innovative cell and gene therapies in Switzerland
    Corporate
  • AI Picture 2_0
    Corporate
    Mar 17, 2022
    Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
    Corporate
  • 01208_300dpi_RGB_0
    Corporate
    Mar 17, 2022
    Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor
    Corporate

Novartis Ireland

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Other Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2023 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
Site intended for audiences in Ireland IE208268 May 22